Oral and Oropharyngeal Squamous Cell Carcinoma: Advances in Research
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 March 2022) | Viewed by 34782
Special Issue Editor
Interests: OMFS; drug therapy; 3D bioprinting; bone regeneration; tissue engineering
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The main goal of this Special Issue of the journal Cancer is to find answers for a better understanding of oral squamous cell carcinoma (OSCC) and to point out modern therapies that are state-of-the-art.
The biological and immunological aspects of OSCC are of particular interest, especially for estimating the prognosis of this type of cancer, as well as specific clinical data related to the use of prognostic and therapeutic markers. Moreover, studies aimed at understanding important complications in the therapy of OSCC (e.g., the mechanism of metastasis and epithelial–mesenchymal transition (EMT)), the failure of specific therapies (e.g., of immunotherapy or chemotherapy due to the mutation burden), as well as that of transplants (e.g., flaps or dental implants after OSCC therapy) are welcome.
Metabolic, immunological, and other specific features of OSCC (e.g., stem cell markers, hypoxic status) are also of interest.
Therefore, we welcome manuscripts describing biological, immunological, and physiological markers of OSCC and the translation of these data into modern techniques for routine clinical practice for more specific and individual therapeutic options for this disease.
Prof. Sven Otto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Prognosis
- metastasis
- immune escape
- metabolism
- mutation
- hypoxia
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.